Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries
Despite Novo Nordisks Wegovy discounts, Eli Lillys Mounjaro maintains prescription dominancethanks to superior clinical outcomes
The SURMOUNT trials with tirzepatide demonstrated weight loss exceeding 20% at the highest doses, substantially more than what orforglipron has achieved in Phase 3
The research has not yet been published in a peer-reviewed journal
Many athletes, gym-goers, and individuals aiming for weight management include L-Carnitine as part of their supplement routine
"This transaction advances one of our most compelling value-creation opportunities, strengthens our financial flexibility, and supports our strategy to deliver long-term value for our shareholders," LaBelle said